News Quantified

XGN – exagen inc. (US:NASDAQ)

Exagen Inc. (NASDAQ: XGN) had its price target raised by analysts at Cantor Fitzgerald from $5.00 to $7.00. They now have an "overweight" rating on the stock.

5/13

08:00 am

xgn

Medium

Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year

Exagen Announces Campaign for Lupus Awareness Month [Yahoo! Finance]

Exagen Announces Campaign for Lupus Awareness Month

Lupus Foundation of America Drives Nationwide Effort to Make Lupus Visible During Lupus Awareness Month [Yahoo! Finance]

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}